LinkedIn




Hot Topics


In Memoriam: Johanna Buck

Posted August 10, 2015

From Dr Bruce Agins,

With deep sadness, I want to inform you of the loss of our colleague and QI expert, Johanna Buck. Johanna worked as a nearly full-time consultant with the quality program for nearly 15 years, and then part-time following her diagnosis of colon cancer which she fought fiercely until the bitter end this past weekend. Johanna was a masters-prepared nurse who worked for many years as a front-line provider and then senior administrator at what was then known as Community Health Network. She was an early adopter of QI there. Johanna was an ideal coach: she had the technical expertise, infinite patience and empathy that allowed her to meet her providers “where they were at,” tailoring her coaching to their needs perfectly. She instinctively understood the organizational dynamics and contexts that were so important to the effectiveness of her work, just as her personality was well-suited to building the relationships that allowed her to function and be well-received in the way that is so essential for the success of a long-term coach.

Few people realize how instrumental Johanna’s work was in building our statewide quality program. She didn’t ask for recognition and calmly oversaw her initiatives. Johanna, in fact, was the developer of our QI network model, and actually led our first successful QI learning network, which involved all of the HHC facilities back in the early 2000s. This work was also the first QI work to focus on retention – building a model that ultimately shaped our work here and nationally, serving as the foundational QI-based approach to retention.

After her initial rounds of treatment, she returned to work full-time engaging to the maximum extent possible and continued to be a sounding board for several of us. We will miss her clear-sighted perspective, her dedication to improvement, her compassion and her warm smile.

Johanna leaves her husband Glenn, and twin daughters, Annie and Katie who are in their mid-20s. We pass along this information.

 

^ Return to Top


Updates to the Adult and Adolescent Opportunistic Infections Guidelines (8-28-2015)

Posted August 28, 2015

The Bacterial Enteric Infections section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was recently updated. This update provides new data on ciprofloxacin resistance in Shigella sonnei and improved clinical success when Clostridium difficile infection (CDI) is treated with vancomycin. Limited data suggest fecal microbiota therapy for recurrent CDI may be safe and successful in HIV-infected patients.

 

^ Return to Top


FDA Updates Rilpivirine Labeling (8-27-2015)

Posted August 27, 2015

“On August 26, 2015 the Edurant (rilpivirine) product labeling was updated to include the use of rilpivirine in combination with other antiretroviral agents for the treatment of HIV-1 infection to include treatment-naïve pediatric patients from 12 to less than 18 years of age with HIV-1 RNA less than or equal to 100,00 copies/mL. … In addition to the addition of the adolescent data to the label, changes were made the Warnings and Precautions with respect to Depressive Disorders and updates to the adrenal function subsection in section 6 Adverse Reactions.”

The updated labeling will be available at the FDA website.

More information is available:

 

^ Return to Top


NYS Clinical Education: HIV Webinar Series, New CME Courses and Modules (8-25-2015)

Posted August 25, 2015

This Month in HIV: The Role of the Primary Care Clinician in HIV Care

Wednesday, September 16, 2015 – Webinar

Registration for this training is required. For more information, please contact Robert Walsh at rwalsh@chpnet.org or 212-636-1315

This webinar is part of a monthly series: http://ceitraining.org/thismonthinhiv/

Please visit http://ceitraining.org/events/ to view all of our upcoming events.

New CME Courses

The Clinical Education Initiative is pleased to announce the availability of two new CME courses. All courses are free and can be taken online at any time.

Please visit https://www.ceitraining.org/sp2/ today to sign-up for these training opportunities.

New Learning Module

The Clinical Education Initiative is pleased to announce the availability of a new learning module. All modules are free and can be viewed online at any time.

Please visit http://www.ceitraining.org/resources/audio-video.cfm to view all of our learning modules.

 

^ Return to Top


HIV Training NY: HIV Resources for Working with Older Adults (8-21-2015)

Posted August 21, 2105

New York State Department of Health AIDS Institute: HIV Training NY

Ending the Epidemic, AIDS Institute Target HIV Prevention and Treatment Resources to Older Adults

Governor Cuomo’s Ending the Epidemic Blueprint recognizes the need to prevent HIV among older adults and to retain HIV-positive older adults in care. And the need is critical. Half the all people living with HIV/AIDS in New York State are older than age 50, and new infection rates remain high. The ETE blueprint calls for making HIV testing more accessible to older adults, promoting linkage to care and retention; and addressing HIV/HCV co-infection. The AIDS Institute currently offers trainings, webinars, and published materials that address the goals of the ETE blueprint – emphasizing HIV prevention among older adults and care and retention for those with HIV/AIDS. Whether you’re an AI contractor, community-based organization, or public health department, check out the following resources to help you better serve older people with HIV/AIDS.

Face-to-face trainings

Surviving and Thriving: Older Gay Men and MSM Living with HIV

Working with Older Adults Living with HIV/AIDS

Ending the Epidemic webinar series

Ending the Epidemic and Older Adults: Wednesday, Nov. 18, 1:00-2:30 pm

To register: http://hivtrainingny.org/Account/LogOn?crs=1445

Webinars

Resiliency of Older Adults Living with HIV

Archived webinars

Older Adults and HIV: Comorbidities and Retention in Care , Part I
Older Adults and HIV: Substance Use and Depression, Part II
Older Adults and HIV: Social Isolation and Social Supports, Part III
Older Adults and HIV: Sex and Prevention Burnout, Part IV

For a list of all trainings, go to: http://www.hivtrainingny.org/

Publications

Sex Never Gets Old (booklet)
Sex Never Gets Old: Age Doesn’t Protect You from AIDS (four posters)
Older. Wiser. More Responsible (booklet)
Older. Wiser. More Responsible (poster)

For a list of all publications, go to: https://www.health.ny.gov/diseases/aids/general/publications/index.htm
_________________________________________________________________________________
To register for any course, click on the appropriate registration link and enter your account log-in information. If you do not have an account with hivtrainingny.org, you will need to sign up for one prior to registering for a course. For registration assistance, please contact the NYSDOH AIDS Institute’s HIV Education and Training Program at (518) 474-3045.

 

^ Return to Top


OMD AIDS Institute: Quick News Update (8-16-2015)

Posted July 23, 2015

OMD SCREENSHOT – August 16, 2015

  • The abstract submission period for the Part A Quality Conference “The Power of Quality Improvement: Ryan White Part A Providers Work to End the Epidemic” has been extended to September 15th. Submit abstracts online here.
  • Updated HIV/HAV Co-infection Guidelines are available here.
  • Providing Primary Care to Transgender Adults,” a bulletin from City Health Information, is available here.
  • Opportunities for staff, graduate students, and patients in your program to apply for the Beryl Institute 2015 Patient Experience Grant and Scholar Programs are available here.
  • QI Projects on linkage to care and viral load suppression, implemented by the Monroe County Department of Public Health and Suffolk County Health Services respectively, will be presented at the 2015 National HIV Prevention Conference.
  • The City of Rochester has partnered with Trillium Health and the Mocha Center to support Governor Cuomo’s Ending the Epidemic Initiative. More information is available here.
  • The CDC STD Prevention Science Series webinar will feature Dr. Stefan Baral discussing results of systematic reviews of HIV/STI burden among MSM, and TG women in various income settings on Thursday, September 3rd from 11am to 12pm ET.

 

^ Return to Top


CHI: Providing Primary Care to Transgender Adults (8-12-2015)

Posted August 12, 2015

The NYC Department of Health and Mental Hygiene’s City Health Information (CHI) has released Providing Primary Care to Transgender Adults bulletin.

For more information, please visit http://www.nyc.gov/html/doh/html/data/chi.shtml

 

^ Return to Top


NYS Clinical Education: Needs Assessment, HIV Intensive Training Preceptorship (8-12-2015)

Posted August 12, 2015

2015 Organization Needs Assessment

Please tell us your organization’s HIV, HCV, and STD clinical education needs by completing the CEI 2015 organizational needs assessment. The purpose of this Needs Assessment is to survey your organization’s current and emerging educational, training, and capacity-building needs so that we can better serve you. Thank you.

HIV Intensive Training Preceptorship

Wednesday, October 28, 2015 – Thursday, October 29, 2015, New York, NY.

Registration is now open. This preceptorship is free and open to New York State clinicians. For more information, please contact Naomi Harris at naoharris@chpnet.org or 212-523-5954

Please visit http://ceitraining.org/events/ to view all of our upcoming events.

For more information, please visit http://www.ceitraining.org/

 

^ Return to Top


Update to Recommendations for Testing, Managing, and Treating Hepatitis C: Management of Acute HCV Infection (8-7-2015)

Posted August 7, 2015

AASLD and the Infectious Diseases Society of America (IDSA), in collaboration with the International Antiviral Society-USA (IAS-USA) just released a new section on www.hcvguidelines.org. This section provides guidance on the diagnosis and medical management of acute HCV infection, which is defined as presenting within six months of the exposure. During this time, there is a 20% to 50% chance of spontaneous resolution of infection. In the past, cure rates of acute infection with IFN-based treatment were very high. The present guidance reflects current trends transitioning toward safer, IFN-sparing treatments of chronic infection and the implications on the approach to acute hepatitis C treatment. Visit www.hcvguidelines.org to view the new section.

 

^ Return to Top


Updated HHS Perinatal Antiretroviral Treatment Guidelines Released (8-6-2015)

Posted August 6, 2015

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States.

For a complete preview of key updates to the guidelines, please see What’s New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the text and tables in the PDF version of the guidelines.

To view or download the guidelines, go to the Perinatal Guidelines section of AIDSinfo. Separate PDF files of the tables or recommendations can also be downloaded from the page.

 

^ Return to Top


Tivicay (dolutegravir) and Triumeq (abacavir/dolutegravir/lamivudine) Product Labeling was Updated (8-5-2015)

Posted August 5, 2015

The Tivicay (dolutegravir) and Triumeq (abacavir/dolutegravir/lamivudine) product labeling was updated with drug-drug interaction information.

Section 7 Drug Interactions was updated to include a statement that in vitro, dolutegravir was not a substrate of OATP1B1 or OATP1B3. Additionally, the following information was added to section 7.

  • If TIVICAY is used with carbamazepine adjust dose of TIVICAY to 50 mg twice daily in treatment-naïve or treatment-experienced, INSTI-naïve patients. Use alternative treatment that does not include carbamazepine where possible for INSTI-experienced patients with certain INSTI-associated resistance substitutions or clinically suspected INSTI resistance.
  • If TRIUMEQ is used with carbamazepine adjust dolutegravir dose to 50 mg twice daily. An additional dolutegravir 50 mg dose (TIVICAY 50 mg) should be taken, separated by 12 hours from TRIUMEQ
  • When TIVICAY is used with metformin, limit the total daily dose of metformin to 1,000 mg either when starting metformin or TIVICAY. When stopping TIVICAY, the metformin dose may require an adjustment. Monitoring of blood glucose when initiating concomitant use and after withdrawal of TIVICAY is recommended.
  • When TRIUMEQ is used with metformin, limit the total daily dose of metformin to 1,000 mg either when starting metformin or TRIUMEQ. When stopping TRIUMEQ, the metformin dose may require an adjustment. Monitoring of blood glucose when initiating concomitant use and after withdrawal of TIVICAY is recommended.

Additionally, the TRIUMEQ label, section 6.1 Less Common Adverse Reactions Observed in Clinical Trials section was updated to be consistent with the TIVICAY label as follows: Psychiatric: Suicidal ideation, attempt, behavior, or completion. These events were observed primarily in subjects with a pre-existing history of depression or other psychiatric illness.

You can view the complete label at drugs@fda or dailymed.

Please visit http://content.govdelivery.com/accounts/USFDA/bulletins/1130c15 to view the FDA bulletin.

Please visit http://www.fda.gov/default.htm for more information from the FDA.

More information is available:

 

^ Return to Top


IAS Conference Recap (8-5-2015)

Posted August 5, 2015

FEATURED COVERAGE
HIV/AIDS fight advancing on multiple fronts, according to researchers

Encouraging developments in therapy and prevention were among the good-news stories coming out of the eighth international IAS conference in Vancouver. (CBC News)
Read full post >>

EMERGING CONVERSATIONS
JIAS Supplement
PrEP Implementation Science: State-of-the-Art and Research Agenda
This special issue of JIAS is aimed at contributing to a scholarly discussion of current conditions surrounding PrEP implementation, potential impact and efficiency, social science concerns and the study of PrEP implementation in specific country cases.
Read >>
Publication
Consolidated guidelines on HIV testing services
By WHO
These guidelines bring together existing guidance relevant to the provision of HIV testing services (HTS) and addresses issues and elements for effective delivery of HTS that are common in a variety of settings, contexts and diverse populations.
Read >>
Blog
Two landmark studies provide evidence to recommend earlier initiation of antiretroviral therapy
By Leanne Gray, FHI 360
Results from the START and HPTN 052 studies presented at IAS 2015 provide conclusive evidence of the benefits of ART beyond viral suppression.
Read >>

Much more conference recap information can be viewed by clicking here.

 

^ Return to Top


National HIV/AIDS Strategy: Updated to 2020 (7-30-2015)

Posted July 30, 2015

NATIONAL HIV/AIDS STRATEGY: UPDATED TO 2020
In July 2015, the White House released the National HIV/AIDS Strategy for the United States: Updated to 2020. This Update reflects the work accomplished and the new scientific developments since the original Strategy was released in 2010.

Click here to download (PDF)

EXECUTIVE SUMMARY OF THE UPDATE
Excerpted from the official document, this is a brief synopsis of the National HIV/AIDS Strategy.
Click here to download (PDF)

EXECUTIVE ORDER
President Barack Obama issued this Executive Order releasing the National HIV/AIDS Strategy: Updated to 2020 on July 30, 2015.
Click here to view

FACT SHEET
This White House fact sheet provides a brief overview of the National HIV/AIDS Strategy: Updated to 2020. This document is ideal for use as a handout to educate others about the Strategy.
Click here to view

The following resources from AIDS.gov offer more information on the updated strategy:

 

^ Return to Top


Medicaid Update: July (7-30-2015)

Posted July 30, 2015

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the July 2015 Medicaid Update.

Please click the link below to download the current edition.

http://www.health.ny.gov/health_care/medicaid/program/update/2015/jul15_mu.pdf (PDF)

To see a list of all of the 2015 DOH Medicaid Updates, please visit http://www.health.ny.gov/health_care/medicaid/program/update/2015/index.htm

 

^ Return to Top


HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Releases Statement Regarding the START and TEMPRANO Trial Results (7-28-2015)

Posted July 28, 2015

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents has released a statement announcing a change in the rating of the Panel’s recommendation on initiation of antiretroviral therapy (ART) based on the recently published results from the START and TEMPRANO trials. Both of these randomized controlled trials demonstrated greater clinical benefits when ART is initiated in asymptomatic HIV-infected patients who started on ART at CD4 counts >500 cells/mm3 instead of waiting until CD4 counts decline. Based on these results, the Panel’s recommendation remains the same, that ART is recommended for all patients, regardless of pre-treatment CD4 count, but the strength and evidence has been changed to AI for all patients (i.e., strong recommendation, based on randomized controlled trials).

For more information, please see the Panel Statement.

 

^ Return to Top


NYS Clinical Education: Save the Date, New CME Courses and Learning Module (7-28-2015)

Posted July 28, 2015

Save the Date: Testing, Treatment, and Prevention: The Clinician’s Role in Ending the AIDS Epidemic in New York State
Friday, October 30, 2015, Snug Harbor, Staten Island, New York.

Registration opening soon. This conference is free and open to New York State medical providers. For more information, please contact Naomi Harris at naoharris@chpnet.org or 1-212-523-5954

Please visit http://ceitraining.org/events/ to view all of our upcoming events.

New CME Courses
The Clinical Education Initiative is pleased to announce the availability of two new CME courses. All courses are free and can be taken online at any time.

Please visit https://www.ceitraining.org/sp2/ today to sign-up for these training opportunities.

New Learning Module
The Clinical Education Initiative is pleased to announce the availability of a new learning module. All modules are free and can be viewed online at any time.

Please visit http://www.ceitraining.org/resources/audio-video.cfm to view all of our learning modules.

For more information, please visit http://www.ceitraining.org/

 

^ Return to Top


Email Announcement Archives

The HIV Clinical Guidelines Program provides subscribers with email announcements of when new guidelines are posted and existing guidelines are updated.

hivguidelines email announcement archives

hivguidelines Trends, Topics & Updates monthly mailer archives

Subscribe to hivguidelines email announcements

 

^ Return to Top


Hot Topics Archive

Please visit the Hot Topics Archive page.

^ Return to Top